{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T15:54:47Z","timestamp":1784735687256,"version":"3.55.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T00:00:00Z","timestamp":1747353600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100017102","name":"Friends of Leukemia Research Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017102","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["21K20913"],"award-info":[{"award-number":["21K20913"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["23K14719"],"award-info":[{"award-number":["23K14719"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["23K24235"],"award-info":[{"award-number":["23K24235"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["19KK0221"],"award-info":[{"award-number":["19KK0221"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["22H02974"],"award-info":[{"award-number":["22H02974"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007313","name":"The University of Texas MD Anderson Cancer Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007313","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005731","name":"Juntendo University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005731","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010904","name":"Major International Joint Research Programme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010904","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004917","name":"Cancer Prevention and Research Institute of Texas","doi-asserted-by":"publisher","award":["RP160693"],"award-info":[{"award-number":["RP160693"]}],"id":[{"id":"10.13039\/100004917","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004917","name":"Cancer Prevention and Research Institute of Texas","doi-asserted-by":"publisher","award":["RP180309"],"award-info":[{"award-number":["RP180309"]}],"id":[{"id":"10.13039\/100004917","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Blood Neoplasia"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.bneo.2025.100121","type":"journal-article","created":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T18:20:38Z","timestamp":1747678838000},"page":"100121","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["PPAR\u03b3-induced upregulation of fatty acid metabolism confers resistance to venetoclax and decitabine therapy in AML"],"prefix":"10.1016","volume":"2","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0162-1162","authenticated-orcid":false,"given":"Kotoko","family":"Yamatani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4166-4781","authenticated-orcid":false,"given":"Tatsuro","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaori","family":"Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdullah","family":"Khasawneh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9043-538X","authenticated-orcid":false,"given":"Abhishek","family":"Maiti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihong","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kala","family":"Hayes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinya","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9003-0390","authenticated-orcid":false,"given":"Courtney D.","family":"DiNardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoping","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0422-8152","authenticated-orcid":false,"given":"Shuko","family":"Nojiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3241-5502","authenticated-orcid":false,"given":"Yasushi","family":"Okazaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1144-1958","authenticated-orcid":false,"given":"Michael","family":"Andreeff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9347-2212","authenticated-orcid":false,"given":"Marina","family":"Konopleva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoko","family":"Tabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.bneo.2025.100121_bib1","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1056\/NEJMoa2012971","article-title":"Azacitidine and venetoclax in previously untreated acute myeloid leukemia","volume":"383","author":"DiNardo","year":"2020","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.bneo.2025.100121_bib2","doi-asserted-by":"crossref","first-page":"e724","DOI":"10.1016\/S2352-3026(20)30210-6","article-title":"10-day decitabine with venetoclax for newly diagnosed intensive chemotherapy ineligible, and relapsed or refractory acute myeloid leukaemia: a single-centre, phase 2 trial","volume":"7","author":"DiNardo","year":"2020","journal-title":"Lancet Haematol"},{"issue":"6","key":"10.1016\/j.bneo.2025.100121_bib3","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1158\/2159-8290.CD-22-0939","article-title":"Combinatorial BCL2 family expression in acute myeloid leukemia stem cells predicts clinical response to azacitidine\/venetoclax","volume":"13","author":"Waclawiczek","year":"2023","journal-title":"Cancer Discov"},{"issue":"4","key":"10.1016\/j.bneo.2025.100121_bib4","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1158\/2159-8290.CD-19-0710","article-title":"Monocytic subclones confer resistance to venetoclax-based therapy in patients with acute myeloid leukemia","volume":"10","author":"Pei","year":"2020","journal-title":"Cancer Discov"},{"issue":"12","key":"10.1016\/j.bneo.2025.100121_bib5","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1038\/s41591-018-0233-1","article-title":"Venetoclax with azacitidine disrupts energy metabolism and targets leukemia stem cells in patients with acute myeloid leukemia","volume":"24","author":"Pollyea","year":"2018","journal-title":"Nat Med"},{"issue":"5","key":"10.1016\/j.bneo.2025.100121_bib6","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.ccell.2018.10.005","article-title":"Inhibition of amino acid metabolism selectively targets human leukemia stem cells [published correction appears in Cancer Cell. 2019;35(2):333-335]","volume":"34","author":"Jones","year":"2018","journal-title":"Cancer Cell"},{"issue":"6","key":"10.1016\/j.bneo.2025.100121_bib7","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1158\/0008-5472.CAN-16-1645","article-title":"Bone marrow adipocytes facilitate fatty acid oxidation activating AMPK and a transcriptional network supporting survival of acute monocytic leukemia cells","volume":"77","author":"Tabe","year":"2017","journal-title":"Cancer Res"},{"issue":"1","key":"10.1016\/j.bneo.2025.100121_bib8","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-35198-6","article-title":"Inhibition of FAO in AML co-cultured with BM adipocytes: mechanisms of survival and chemosensitization to cytarabine","volume":"8","author":"Tabe","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.bneo.2025.100121_bib9","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.00155","article-title":"Fatty acid metabolism, bone marrow adipocytes, and AML","volume":"10","author":"Tabe","year":"2020","journal-title":"Front Oncol"},{"issue":"11","key":"10.1016\/j.bneo.2025.100121_bib10","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1182\/blood.2019003988","article-title":"Molecular patterns of response and treatment failure after frontline venetoclax combinations in older patients with AML","volume":"135","author":"DiNardo","year":"2020","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.bneo.2025.100121_bib11","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1038\/s43018-020-00126-z","article-title":"Fatty acid metabolism underlies venetoclax resistance in acute myeloid leukemia stem cells","volume":"1","author":"Stevens","year":"2020","journal-title":"Nat Cancer"},{"issue":"1","key":"10.1016\/j.bneo.2025.100121_bib12","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.cell.2010.02.027","article-title":"A chromatin-mediated reversible drug-tolerant state in cancer cell subpopulations","volume":"141","author":"Sharma","year":"2010","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.bneo.2025.100121_bib13","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.ccr.2010.01.022","article-title":"A transcriptional signature and common gene networks link cancer with lipid metabolism and diverse human diseases","volume":"17","author":"Hirsch","year":"2010","journal-title":"Cancer Cell"},{"issue":"5","key":"10.1016\/j.bneo.2025.100121_bib14","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1002\/ajh.23652","article-title":"BRAF kinase domain mutations are present in a subset of chronic myelomonocytic leukemia with wild-type RAS","volume":"89","author":"Zhang","year":"2014","journal-title":"Am J Hematol"},{"issue":"1","key":"10.1016\/j.bneo.2025.100121_bib15","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","article-title":"STAR: ultrafast universal RNA-seq aligner","volume":"29","author":"Dobin","year":"2013","journal-title":"Bioinformatics"},{"issue":"12","key":"10.1016\/j.bneo.2025.100121_bib16","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol"},{"issue":"43","key":"10.1016\/j.bneo.2025.100121_bib17","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.bneo.2025.100121_bib18","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s13148-019-0613-5","article-title":"Leisure-time physical activity and DNA methylation age-a twin study","volume":"11","author":"Sillanp\u00e4\u00e4","year":"2019","journal-title":"Clin Epigenetics"},{"issue":"1","key":"10.1016\/j.bneo.2025.100121_bib19","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.canlet.2012.11.022","article-title":"Comprehensive DNA methylation and extensive mutation analyses reveal an association between the CpG island methylator phenotype and oncogenic mutations in gastric cancers","volume":"330","author":"Kim","year":"2013","journal-title":"Cancer Lett"},{"issue":"7","key":"10.1016\/j.bneo.2025.100121_bib20","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1182\/blood.2019003084","article-title":"Targeting aberrant DNA hypermethylation as a driver of ATL leukemogenesis by using the new oral demethylating agent OR-2100","volume":"136","author":"Watanabe","year":"2020","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.bneo.2025.100121_bib21","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1158\/1541-7786.MCR-17-0026","article-title":"B-cell receptor signaling regulates metabolism in chronic lymphocytic leukemia","volume":"15","author":"Vangapandu","year":"2017","journal-title":"Mol Cancer Res"},{"issue":"49","key":"10.1016\/j.bneo.2025.100121_bib22","doi-asserted-by":"crossref","first-page":"19345","DOI":"10.1073\/pnas.0709747104","article-title":"Beyond aerobic glycolysis: transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis","volume":"104","author":"DeBerardinis","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"10.1016\/j.bneo.2025.100121_bib23","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/s41419-020-2449-5","article-title":"Enhanced fatty acid oxidation provides glioblastoma cells metabolic plasticity to accommodate to its dynamic nutrient microenvironment","volume":"11","author":"Kant","year":"2020","journal-title":"Cell Death Dis"},{"issue":"3","key":"10.1016\/j.bneo.2025.100121_bib24","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.cmet.2018.06.001","article-title":"Etomoxir inhibits macrophage polarization by disrupting CoA homeostasis","volume":"28","author":"Divakaruni","year":"2018","journal-title":"Cell Metab"},{"issue":"1","key":"10.1016\/j.bneo.2025.100121_bib25","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1038\/s41467-024-45916-6","article-title":"Comprehensive characterization of IFN\u03b3 signaling in acute myeloid leukemia reveals prognostic and therapeutic strategies","volume":"15","author":"Wang","year":"2024","journal-title":"Nat Commun"},{"issue":"10","key":"10.1016\/j.bneo.2025.100121_bib26","doi-asserted-by":"crossref","first-page":"13106","DOI":"10.1096\/fj.202000767R","article-title":"Mitochondrial spare respiratory capacity: mechanisms, regulation, and significance in non-transformed and cancer cells","volume":"34","author":"Marchetti","year":"2020","journal-title":"Faseb j"},{"issue":"9","key":"10.1016\/j.bneo.2025.100121_bib27","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1038\/nsmb.1474","article-title":"Structural basis for the activation of PPARgamma by oxidized fatty acids","volume":"15","author":"Itoh","year":"2008","journal-title":"Nat Struct Mol Biol"},{"issue":"33","key":"10.1016\/j.bneo.2025.100121_bib28","doi-asserted-by":"crossref","first-page":"3818","DOI":"10.1038\/onc.2011.543","article-title":"MiR-27b targets PPAR\u03b3 to inhibit growth, tumor progression and the inflammatory response in neuroblastoma cells","volume":"31","author":"Lee","year":"2012","journal-title":"Oncogene"},{"key":"10.1016\/j.bneo.2025.100121_bib29","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.624112","article-title":"PPARgamma in metabolism, immunity, and cancer: unified and diverse mechanisms of action","volume":"12","author":"Hernandez-Quiles","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"12","key":"10.1016\/j.bneo.2025.100121_bib30","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1158\/2159-8290.CD-19-0270","article-title":"Polyunsaturated fatty acids from astrocytes activate PPAR\u03b3 signaling in cancer cells to promote brain metastasis","volume":"9","author":"Zou","year":"2019","journal-title":"Cancer Discov"},{"issue":"6","key":"10.1016\/j.bneo.2025.100121_bib31","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1038\/s41416-022-02096-8","article-title":"The role of PPAR\u03b3 in prostate cancer development and progression","volume":"128","author":"Hartley","year":"2023","journal-title":"Br J Cancer"},{"issue":"47","key":"10.1016\/j.bneo.2025.100121_bib32","doi-asserted-by":"crossref","first-page":"82491","DOI":"10.18632\/oncotarget.19700","article-title":"PPAR\u03b3 sumoylation-mediated lipid accumulation in lung cancer [published correction appears in Oncotarget. 2019;10(14):1473]","volume":"8","author":"Phan","year":"2017","journal-title":"Oncotarget"},{"issue":"11","key":"10.1016\/j.bneo.2025.100121_bib33","doi-asserted-by":"crossref","DOI":"10.1002\/mgg3.1818","article-title":"Alteration of PPAR-GAMMA (PPARG; PPAR\u03b3) and PTEN gene expression in acute myeloid leukemia patients and the promising anticancer effects of PPAR\u03b3 stimulation using pioglitazone on AML cells","volume":"9","author":"Esmaeili","year":"2021","journal-title":"Mol Genet Genomic Med"},{"issue":"4","key":"10.1016\/j.bneo.2025.100121_bib34","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1097\/00062752-200207000-00006","article-title":"Role of peroxisome proliferator-activated receptor-gamma in hematologic malignancies","volume":"9","author":"Konopleva","year":"2002","journal-title":"Curr Opin Hematol"},{"issue":"3","key":"10.1016\/j.bneo.2025.100121_bib35","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.stem.2012.12.013","article-title":"BCL-2 inhibition targets oxidative phosphorylation and selectively eradicates quiescent human leukemia stem cells","volume":"12","author":"Lagadinou","year":"2013","journal-title":"Cell Stem Cell"},{"issue":"20","key":"10.1016\/j.bneo.2025.100121_bib36","doi-asserted-by":"crossref","first-page":"4233","DOI":"10.1182\/bloodadvances.2020003661","article-title":"Exogenous mitochondrial transfer and endogenous mitochondrial fission facilitate AML resistance to OxPhos inhibition","volume":"5","author":"Saito","year":"2021","journal-title":"Blood Adv"},{"issue":"4","key":"10.1016\/j.bneo.2025.100121_bib37","doi-asserted-by":"crossref","DOI":"10.3390\/metabo13040467","article-title":"Therapy-resistant acute myeloid leukemia stem cells are resensitized to venetoclax + azacitidine by targeting fatty acid desaturases 1 and 2","volume":"13","author":"Culp-Hill","year":"2023","journal-title":"Metabolites"},{"issue":"5","key":"10.1016\/j.bneo.2025.100121_bib38","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.stem.2020.07.021","article-title":"Nicotinamide metabolism mediates resistance to venetoclax in relapsed acute myeloid leukemia stem cells","volume":"27","author":"Jones","year":"2020","journal-title":"Cell Stem Cell"},{"issue":"19","key":"10.1016\/j.bneo.2025.100121_bib39","doi-asserted-by":"crossref","DOI":"10.3390\/ijms221910573","article-title":"The PPAR\u03b1 and PPAR\u03b3 epigenetic landscape in cancer and immune and metabolic disorders","volume":"22","author":"Porcuna","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.bneo.2025.100121_bib40","first-page":"115759","article-title":"Acquired resistance to venetoclax plus azacitidine in acute myeloid leukemia: In vitro models and mechanisms. Biochem","volume":"216","author":"Carter","year":"2023","journal-title":"Pharmacol"},{"issue":"12","key":"10.1016\/j.bneo.2025.100121_bib41","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1007\/s00277-012-1537-8","article-title":"Concomitant inhibition of DNA methyltransferase and BCL-2 protein function synergistically induce mitochondrial apoptosis in acute myelogenous leukemia cells","volume":"91","author":"Tsao","year":"2012","journal-title":"Ann Hematol"}],"container-title":["Blood Neoplasia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950328025000561?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950328025000561?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,25]],"date-time":"2025-08-25T13:11:38Z","timestamp":1756127498000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2950328025000561"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":41,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["S2950328025000561"],"URL":"https:\/\/doi.org\/10.1016\/j.bneo.2025.100121","relation":{},"ISSN":["2950-3280"],"issn-type":[{"value":"2950-3280","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PPAR\u03b3-induced upregulation of fatty acid metabolism confers resistance to venetoclax and decitabine therapy in AML","name":"articletitle","label":"Article Title"},{"value":"Blood Neoplasia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bneo.2025.100121","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 American Society of Hematology. Published by Elsevier Inc. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"100121"}}